Peter R. Flanagan

Peter R. Flanagan

Auto-generated profile, based on publicly available information

Peter R. Flanagan

Division of Oral Biosciences, Dublin Dental University Hospital, & University of Dublin, Trinity College Dublin, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
NLNing-Ning Liu
Ning-Ning Liu
PFPeter R. Flanagan
Peter R. Flanagan
JZJumei Zeng
Jumei Zeng
NJNiketa M. Jani
Niketa M. Jani
MCMaria E. Cardenas
Maria E. Cardenas
JKJulia Koehler
Julia Koehler
Significance: The human fungal pathogen Candida albicans uses the Target of Rapamycin (TOR) signaling pathway to contend with varying host environments and thereby, regulate cell growth. Seeking unknown components of the C. albicans TOR pathway, we identified a phosphate importer, Pho84, and its molecular link to Target of Rapamycin complex 1 (TORC1). Because phosphorus is a critical element for anabolic processes, like DNA replication, ribosome biogenesis, translation, and membrane biosynthesis, TORC1 monitors its availability in regulating these processes. By depleting the central kinase in the TORC1 pathway, we showed that TORC1 signaling modulates regulation of phosphate acquisition. A Food and Drug Administration-approved small molecule inhibitor of Pho84 inhibits TORC1 signaling and potentiates the activity of the antifungals amphotericin B and micafungin.

2 February 2015 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
HRHannah E. Roberts
Hannah E. Roberts
JHJacob Hurst
Jacob Hurst
NRNicola Robinson
Nicola Robinson
HBHelen Brown
Helen Brown
PFPeter Flanagan
Peter Flanagan
SISPARTAC trial investigators
SPARTAC trial investigators
The existence of viral variants that escape from the selection pressures imposed by cytotoxic T-lymphocytes (CTLs) in HIV-1 infection is well documented, but it is unclear when they arise, with reported measures of the time to escape in individuals ranging from days to years. A study of participants enrolled in the SPARTAC (Short Pulse Anti-Retroviral Therapy at HIV Seroconversion) clinical trial allowed direct observation of the evolution of CTL escape variants in 125 adults with primary HIV-1 infection observed for up to three years. Patient HLA-type, longitudinal CD8+ T-cell responses measured by IFN-γ ELISpot and longitudinal HIV-1 gag, pol, and nef sequence data were used to study the timing and prevalence of CTL escape in the participants whilst untreated. Results showed that sequence variation within CTL epitopes at the first time point (within six months of the estimated date of seroconversion) was consistent with most mutations being transmitted in the infecting viral strain rather than with escape arising within the first few weeks of infection. Escape arose throughout the first three years of infection, but slowly and steadily. Approximately one third of patients did not drive any new escape in an HLA-restricted epitope in just under two years. Patients driving several escape mutations during these two years were rare and the median and modal numbers of new escape events in each patient were one and zero respectively. Survival analysis of time to escape found that possession of a protective HLA type significantly reduced time to first escape in a patient (p = 0.01), and epitopes escaped faster in the face of a measurable CD8+ ELISpot response (p = 0.001). However, even in an HLA matched host who mounted a measurable, specific, CD8+ response the average time before the targeted epitope evolved an escape mutation was longer than two years. The cytotoxic T-lymphocyte (CTL) arm of the immune response is thought to play a significant role in the control of HIV-1 infection. Mutations within the HIV-1 genome allow the virus to escape recognition by CTLs and so evade the immune response. These escape mutations have been well documented but observed waiting times to escape within an individual have ranged from days to years. Many studies describing CTL escape have taken a detailed look at a few patients. Our analysis is based on a cohort of 125 clinical trial participants with immunologic and viral sequence data taken at regular longitudinal time points within the first few years of infection. Results suggested that the majority of CTL-related mutations present early in infection had been transmitted in the infecting viral strain as opposed to arising in the new host due to selection pressure imposed by CTLs. Whilst the prevalence of CTL escape mutations in the dataset was high, the incidence of new escape was relatively low; around one third of patients did not drive an escape within the first two years. Patients possessing a ‘protective’ HLA genotype had a significantly shorter waiting time to first escape than those without.

27 December 2017 in mSphere
Verified
Journal Article
Open access
PFPeter R. Flanagan
Peter R. Flanagan
NLNing-Ning Liu
Ning-Ning Liu
DFDarren J. Fitzpatrick
Darren J. Fitzpatrick
KHKarsten Hokamp
Karsten Hokamp
JKJulia R. Köhler
Julia R. Köhler
GMGary Moran
Gary Moran
Candida albicans is the major fungal pathogen of humans and is responsible for a wide range of infections, including life-threatening systemic infections in susceptible hosts. Target of rapamycin complex 1 (TORC1) is an essential regulator of metabolism in this fungus, and components of this complex are under increased investigation as targets for new antifungal drugs. The present study characterized the role of GTR1 , encoding a putative GTPase, in TORC1 activation. This study shows that GTR1 encodes a protein required for activation of TORC1 activity in response to amino acids and regulation of nitrogen starvation responses. GTR1 mutants show increased cell-cell adhesion and biofilm formation and increased expression of genes involved in these processes. This study demonstrates that starvation responses and biofilm formation are coregulated by GTR1 and suggests that these responses are linked to compete with the microbiome for space and nutrients.

15 November 2010 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
EBEleanor Barnes
Eleanor Barnes
PFPeter Flanagan
Peter Flanagan
ABAnthony Brown
Anthony Brown
NRNicola Robinson
Nicola Robinson
HBHelen Brown
Helen Brown
JFJohn Frater
John Frater
A xenotropic murine leukemia virus-related virus (XMRV) has recently been reported in association with prostate cancer and chronic fatigue syndrome,

24 June 2020 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
NRNatalia Redondo
Natalia Redondo
SMSimone Mok
Simone Mok
LMLorraine Montgomery
Lorraine Montgomery
PFPeter R. Flanagan
Peter R. Flanagan
EMEleanor McNamara
Eleanor McNamara
MFMargaret M. Fitzgibbon
Margaret M. Fitzgibbon
Mycobacterium abscessus complex (MABC) are multidrug resistant nontuberculous mycobacteria and cause opportunistic pulmonary infections in individuals with cystic fibrosis (CF). In this study, genomic analysis of MABC was performed to gain greater insights into the epidemiology of circulating strains in Ireland. Whole genome sequencing (WGS) was performed on 70 MABC isolates that had been referred to the Irish Mycobacteria Reference Laboratory between 2006 and 2017 across nine Irish healthcare centres. MABC comprised of 52 isolates from 27 CF patients and 18 isolates from 10 non-CF patients. WGS identified 57 (81.4%) as M. abscessus subsp. abscessus (MAB), 10 (14.3%) as M. abscessus subsp. massiliense (MMAS) and 3 (4.3%) as M. abscessus subsp. bolletii (MBOL). Forty-nine isolates (94%) from 25 CF patients were identified as MAB whereas 3 (6%) isolates from 2 CF patients were identified as MMAS. Among non-CF patients, 44% (8/18) were identified as MAB, 39% (7/18) as MMAS and 17% (3/18) as MBOL. WGS detected two clusters of closely related MAB that included isolates from different CF centres. There was greater genomic diversity of MABC among non-CF compared to CF patients. Although WGS failed to show direct evidence of patient to patient transmission among CF patients, there was a predominance of two different strains of MAB. Furthermore, some MABC were closely related to global strains suggesting their international spread. Future prospective real-time epidemiological and clinical data along with contemporary MABC sequence analysis may elucidate sources and routes of transmission among patients infected with MABC.

20 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PFPeter R Flanagan
Peter R Flanagan
JFJessica Fletcher
Jessica Fletcher
HBHannah Boyle
Hannah Boyle
RSRazvan Sulea
Razvan Sulea
GMGary Moran
Gary Moran
DSDerek Sullivan
Derek Sullivan
The TLO genes are a family of subtelomeric ORFs in the fungal pathogens Candida albicans and C. dubliniensis encoding a subunit of the Mediator complex homologous to Med2. The more virulent pathogen C. albicans has 15 copies of the gene whereas the less pathogenic species C. dubliniensis has only two. To investigate if expansion of the TLO repertoire in C. dubliniensis has an effect on phenotype and virulence we expressed three representative C. albicans TLO genes (TLOβ2, TLOγ11 and TLOα12) in a wild type C. dubliniensis background, under the control of either their native or the ACT1 promoter. Expression of TLOβ2 resulted in a hyperfilamentous phenotype, while overexpression of TLOγ11 and TLOα12 resulted in enhanced resistance to oxidative stress. Expression of all three TLO genes from the ACT1 promoter resulted in increased virulence in the Galleria infection model. In order to further investigate if individual TLO genes exhibit differences in function we expressed six representative C. albicans TLO genes in a C. dubliniensis Δtlo1/Δtlo2 double mutant. Differences were observed in the ability of the expressed CaTLOs to complement the various phenotypes of the mutant. All TLO genes with the exception of TLOγ7 could restore filamentation, however only TLOα9, γ11 and α12 could restore chlamydospore formation. Differences in the ability of CaTLO genes to restore growth in the presence of H2O2, calcofluor white, Congo red and at 42°C were observed. Only TLOα3 restored wild-type levels of virulence in the Galleria infection model. These data show that expansion of the TLO gene family in C. dubliniensis results in gain of function and that there is functional diversity amongst members of the gene family. We propose that this expansion of the TLO family contributes to the success of C. albicans as a commensal and opportunistic pathogen.